EU Commission publishes latest device classification and borderline decisions
This article was originally published in Clinica
The European Commission's Medical Devices Expert Group on borderline and classification cases has reached a consensus on the definition of a number of products that have "raised doubts". These doubts include devicesfor the determining bacterial contamination in blood products, eye drops, independent in-vivo dosimeters and biofunctional clothes, among other things. The expert group, whose work is to ensure a uniform approach in the regulation of medical devices, also made decisions on how applications for certain classification rules should be interpreted. For further details, see version 1.9 (dated March 2011) of the European Commission’s Manual on Borderline and Classification in the Community Regulatory Framework for Medical Devices, just published on the European Commission website: http://ec.europa.eu/consumers/sectors/medical-devices/files/wg_minutes_member_lists/version1_9_borderline_manual_en.pdf
You may also be interested in...
February sees some vitally important issues on the European Commission’s agenda, including areas where the medtech sector has been clamoring for progress in terms of clarity over the Commission's thinking and guidance documents. This year's meetings are plentiful and critical.
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.